Clinical Trials Directory

Trials / Completed

CompletedNCT02819128

Investigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
722 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: Homeless people have infections not diagnosed with a potential impact on their health status. Main Purpose: Improve the etiological diagnosis of endemic and/or emerging pathologies among homeless people.

Detailed description

In Marseilles, the population of homeless is estimated at 1500 individuals, including 800 usually sleeping in the street, 600 in foster homes and a hundred in the structures of care. The precarious living conditions of homeless persons promote the emergence or re-emergence of many communicable infectious diseases homeless people whose symptoms are often overlooked by the subject and rarely established etiologic diagnosis. Among these diseases, frequently described in the literature are infestation by lice and infectious diseases that they transmit (Bartonella quintana), skin infections, hepatitis E and C and finally the infection with Tropheryma Whipplei. In this study we propose to systematically in homeless subject an etiological diagnosis of pathogens at the origin of these diseases (i) to improve knowledge (ii) to improve their management, (iii) to limit the contagion.

Conditions

Interventions

TypeNameDescription
OTHERSwabs skin, pharyngeal, and blood sampleCollection of one blood sample with a volume of 10 mL (2 tubes of blood 5 mL ) and 2 swabs ( throat and skin ).
OTHERCollection of body liceFor the subjects infested with body lice , if they want, their underwear will be recovered and sent to the laboratory to measure the resistance to permethrin.

Timeline

Start date
2014-01-25
Primary completion
2020-09-30
Completion
2022-10-26
First posted
2016-06-30
Last updated
2023-04-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02819128. Inclusion in this directory is not an endorsement.